Related Experiment Video

Updated: Dec 9, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.8K

Addressing Comorbidities in Heart Failure: Hypertension, Atrial Fibrillation, and Diabetes

Aakash Bavishi1, Ravi B Patel2

  • 1Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Heart Failure Clinics
|September 5, 2020
PubMed

Insights

Managing common comorbidities like hypertension, atrial fibrillation, and diabetes is crucial for heart failure (HF) patients. This review details the epidemiology, management, and new therapies for these conditions to improve HF outcomes.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Public Health

Background:

  • Heart failure (HF) presents a significant and growing global health challenge.
  • Effective management of co-existing conditions is vital for preventing HF progression and reducing hospitalizations.
  • Optimizing patient quality of life necessitates addressing common comorbidities within the HF syndrome.

Purpose of the Study:

  • To review the epidemiology, current management strategies, and novel therapeutic approaches for key comorbidities in heart failure patients.
  • To elucidate the intricate relationship between hypertension, atrial fibrillation, and diabetes mellitus with the overall heart failure syndrome.
  • To provide a comprehensive resource for clinicians managing patients with complex cardiovascular conditions.

Main Methods:

  • Literature review synthesizing current evidence on heart failure comorbidities.
  • Analysis of epidemiological data for hypertension, atrial fibrillation, and diabetes mellitus in HF populations.
  • Examination of established and emerging treatment guidelines and therapies.

Main Results:

  • Hypertension, atrial fibrillation, and diabetes mellitus are highly prevalent in HF patients, significantly impacting prognosis.
  • Integrated management approaches targeting these comorbidities can improve clinical outcomes and reduce healthcare burden.
  • Emerging therapies offer new avenues for optimizing treatment in patients with combined HF and these conditions.

Conclusions:

  • Addressing hypertension, atrial fibrillation, and diabetes mellitus is a cornerstone of optimal heart failure management.
  • A multidisciplinary approach is essential for effectively managing the complex interplay of these conditions.
  • Further research into novel therapeutic strategies is warranted to improve long-term outcomes for heart failure patients with comorbidities.

Keywords:
Atrial fibrillationDiabetes mellitusHeart failureHypertensionPrevalence

More Related Videos

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

446
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.2K

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
125
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
737
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
149
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
303
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
674
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
555